搜尋結果
Risk Appetites Roaring Anew in Wall Street’s Unflappable Markets
Bloomberg· 23 小時前To get a sense of the speculative euphoria in risky assets right now, consider Friday’s trading ...
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 24 小時前Johnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, ...